Alva-Amco Pharmacal has been sold to Kobayashi Pharmaceutical
Based in Niles, Illinois, Alva-Amco Pharmacal is a leading provider of branded over-the-counter (OTC) consumer health products across a number of product categories, including skin care, women’s health, antifungals, upset stomach and pain treatments. For decades, Alva-Amco has provided safe and effective OTC treatments that allow consumers to live well and take charge of their health. The company sells its portfolio of specialty brands across all major pharmacies, grocery stores, mass retailers and online channels in the United States and Canada. For more information, please visit www.alva-amco.com.
Lincoln acted as an advisor to Alva-Amco, working closely with the Alva-Amco management team and shareholders throughout the sale process. Terms of the transaction were not disclosed.
Lincoln was a valued partner throughout the transaction, exceeding expectations and enabling management to remain focused on running the business. We are excited that Lincoln helped us find the right partner at this exciting time in our industry, and we are thrilled to join with Kobayashi as we embark on the next phase of our growth.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce that it has advised The Vet Connection on its sale to Pets at Home Group PLC (LSE:PETS)
Lincoln International is pleased to announce that it has advised shareholders and management of Corndel, the UK's fastest growing leadership and digital skills training company, on its investment from THI Investments
Lincoln International is pleased to announce that Evans Capacitor Company has been sold to Arcline Investment Management
Lincoln International is pleased to announce that it has advised the shareholders of ASSEPRO, the leading independent Swiss insurance broker, on its sale to EMZ Partners